Stock Under $10 with 50-100% upside potential - 14 Days FREE!

10 Best Dow Dividend Stocks for 2011

Stock quotes in this article: HPQ, MRK, UTX, MSFT, CVX, JPM, KO 

6. Merck (MRK) is a global pharmaceutical company.

12-Month Sales Growth: 88%
12-Month Net Income Growth: -2%
Quarterly Operating Profit Margin: 30%
Cash Flow Multiple: 12 (7% peer premium)
Analysts' Median Target: $41.65
3-Year Dividend Growth: 0%
Dividend Yield: 4.2%
Payout Ratio: 54%

2011 Catalyst: Merck is a solid dividend stock. Its 4.2% yield is third-highest in the blue-chip Dow. However, it hasn't increased the distribution since 2004. As with Pfizer, patent expiry is a concern.

However, analysts see value in Merck shares. A forward earnings multiple of 9.4, a book value multiple of 2 and a sales multiple of 2.5 represent 20%, 61% and 22% industry discounts. The 2009 purchase of Schering-Plough has bolstered earnings, but one-time charges have plagued recent results, most recently, a $950 million reserve related to a recall.

Emerging markets are a growth venue. That geographic segment added 18% of quarterly sales.

Bullish Scenario: Deutsche Bank forecasts that Merck's stock will advance 34% to $48.

Bearish Scenario: Jefferies values the shares at $37.80, implying 5% of upside.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,307.17 -80.41 -0.52%
NASDAQ 3,463.30 -38.82 -1.11%
S&P 500 1,655.35 -13.81 -0.83%
US 10 Yr 2.026% +0.082

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs